Regeneron says its antibody treatment 'may be' less effective against omicron | The Hill: Healthcare Policy

Regeneron said Tuesday that its COVID-19 antibody treatment “may be” less effective against the new omicron variant, though tests are ongoing. The statement shows how the new variant is shaking up the response to COVID-19, though there is still...